Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II intensified ChLVVP/ABVVP chemotherapy in advanced Hodgkin lymphoma
2006-005004-14Phase 2Terminated
- Sponsor
- European Institute of Oncology
- Start
- Apr 2007
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of chlorambucil, vinblastine, procarbazine, prednisone, doxorubicin and 4 more in Hodgkin lymphoma (HL), sponsored by European Institute of Oncology. Primary endpoint: Progression-free survival at 3 years. Started Apr 2007; status: terminated.
02
Drugs
chlorambucilvinblastineprocarbazineprednisonedoxorubicin
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on 2006-005004-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005004-14.